The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...
Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.
AbbVie’s Skyrizi was responsible for the highest TV advertising outlay in pharma in most months of 2024, but 2025 is starting ...
Novartis has become the latest drugmaker to get in trouble over an employee’s LinkedIn likes. The U.K. | Novartis has become ...
FDA is required to ensure that prescription drug ads be truthful, not misleading, and balanced. But while Hims’ ad touts its ability to prescribe and dispense GLP-1 drugs to patients, with text and ...
According to Harvard Ad Watch, which was launched in 2022 to track such ads, the federal Food and Drug Administration eased restrictions to allow drug companies to advertise directly to consumers ...
In 2024, such arrangements were the focus of proposed legislation targeting promotional statements, specifically the Protecting Patients from Deceptive Drugs Ads Online Act (the “Act”), and ...
said the ad violates a federal rule that requires drug ads not to be false or misleading. The ad has been posted on YouTube in advance of Sunday's title game between the Philadelphia Eagles and ...